ABSTRACT
Aim: The aim of the present study was to characterize the zinc oxide nano particle incorporated Chitosan (ZnO-NP-CS) and its antimicrobial activity. Methodology: Zinc oxide nanoparticles (ZnO-NP) were prepared by sol-gel method and Minimum Inhibitory Concentration (MIC), Minimum bactericidal Concentration (MBC) and agar well diffusion method was used for the assessment of antibacterial activity of ZnO-NP and ZnO-NP-CS as well. Results: In UV–spectroscopy, blue shift in wavelength (~365 nm) corresponding to bulk ZnO particles (~385 nm) indicates the nano size. In SEM image, ZnO-NP appeared as nano flake shape and ZnO-NP treated Methicillin resistant Staphylococcus aureus and Pseudomonas aeruginosa (PA) bacteria illustrates leakage of intracellular content, fusion and shrinkage of bacteria, respectively. The MIC of ZnO-NP for most of food pathogens were between 0.01 to 0.1mg. Lower MIC was observed for Vibrio cholerae and Listeria monocytogenes; higher MIC was observed for Bacillus cereus and Pseudomonas aeruginosa. In antibiogram assay, the zone of inhibition of ZnO-NP-CS was equal to commercial antibiotics against Multiple Drug Resistant bacteria. Interpretation: The combined effect of ZnO-NP and chitosan is better than the individual component, i.e., around 5–15 mm wider zone of inhibition than chitosan. ZnO-NP-CS can be a suitable alternative for the treatment of wound infected by multiple drug resistant bacteria
ABSTRACT
Children with Down's syndrome and congenital heart defects have multiple problems. The role of cardiac surgery in the management of these patients was investigated by reviewing the clinical data, hospital course and follow-up of 21 patients (9 males and 12 females, age range 1 month to 14 years) with Down's syndrome and congenital heart defects operated in our institute. Twelve (57%) of these were infants and nine (43%), older children. Five were in congestive cardiac failure, four were hypothyroid. The heart lesions ranked in incidence as follows: atrioventricular septal defect 7 (33.3%), tetralogy of Fallot 3 (14.3%), tetralogy of Fallot & atrioventricular septal defect both 2 (9.5%), double outlet right ventricle with pulmonary stenosis 1 (4.8%), patent ductus arteriosus 2 (9.5%), patent ductus arteriosus plus coarctation 1 (4.8%), ventricular septal defect 2 (9.5%), atrial septal defect plus ventricular septal defect 1 (4.8%), atrial septal defect plus patent ductus arteriosus plus right pulmonary artery stenosis 1 (4.8%) and transposition of great arteries with multiple ventricular septal defect 1 (4.8%). Four (19%) patients had palliative procedures while the rest (81%) underwent primary repair. All survived the operation. The post-operative period was complicated in 6 (28.5%), with respiratory infections in 3, pulmonary hypertensive crisis in 2 and complete heart block in 1. The early mortality was 0, while there were 2 (9.5%) late deaths. The number of hospitalisations was markedly reduced according to the parents. Follow-up showed near normal pulmonary artery pressure in 50 percent children with large shunts and a good developmental spurt was seen in 60 percent. From a purely surgical viewpoint, the prognosis for children with Down's syndrome and congenital heart disease is good.